American Scientific Resources Commences Production of Heart Smart System Initial Commercialization Scheduled for 2005 Fourth Quarter
American Scientific Resources today announced that it has begun manufacturing of its Heart Smart System™ product line, a unique line of nutritional supplements designed to support and maintain a healthy heart.
NEW PALTZ, NY (PRWEB) November 10, 2005
American Scientific Resources (PNK: ASFX) American Scientific Resources today announced that it has begun manufacturing of its Heart Smart System™ product line, a unique line of nutritional supplements designed to support and maintain a healthy heart.
The company plans to introduce Heart Smart Foundation Supplement™, the first product in the Heart Smart System portfolio, in November 2005. The high performance nutraceutical supplement has been proven in independent clinical studies to help protect against heart disease, lower blood pressure, increase circulation as well as maintain Cholesterol, Triglycerides, Homocysteine, LP(a) within normal ranges.
The Heart Smart Foundation Supplement™ is the only supplement to blend Coenzyme Q10 (CoQ10), Vitamin B6, Vitamin B12, Vitamin E, Folic Acid, Plant Sterols and Omega 3 Fatty Acids. Independent clinical studies have demonstrated that the patented Hydro Q-Sorb™ technology used in this supplement produces 300% higher CoQ10 blood serum levels than any other CoQ10 supplement on the market.
Walter Lambert, chief executive officer of American Scientific, stated, “We are very excited to begin production of our flagship product line. The Heart Smart Foundation Supplement™ will serve as the cornerstone of our Heart Smart System™ lineup as we believe it is the most effective and efficacious CoQ10 supplement, capable of adding years to people’s lives.”
Mr. Lambert continued, “Our plan is to begin commercialization of our full Heart Smart System product line, totaling nine supplements, before the end of the 2005 fourth quarter. We expect our Heart Smart infomercial, featuring celebrities Gary Collins and MaryAnn Mobley as spokespersons and leading medical experts, will serve as the primary method of introducing our unique product offering to consumers and expanding our presence in the multi billion-dollar nutritional supplement market.”
No assurances can be given that the Heart Smart Foundation Supplement™ or the Heart Smart System™ product line will be introduced timely.
About American Scientific Resources
American Scientific Resources, Inc. is an emerging holding company based in upstate New York that provides a broad range of healthcare and medical products distributed primarily by surgical supply dealers and retail drug chains. The company is comprised of three core operating subsidiaries: 1) Heart Smart System, Inc., the company’s flagship product offering focused on the successful prevention of cardiovascular disease using its patented CoQ10 supplement 2) Kidz-Med, Inc., a leading brand of safe and innovative pediatric products, and 3) Ulster Scientific, Inc., a distributor of unique medical products and laboratory diagnostic equipment founded in 1974. American Scientific Resources’ growing, national customer base includes Walgreens, CVS, Cardinal Health and Fisher Scientific.
SAFE HARBOR STATEMENT: This news release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward - looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements, including the risks that our products may not achieve customer acceptance or that they will not perform as expected, that customer trials will not lead to future sales, and other risks identified in our public filings. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof and DVS undertakes no obligation to update such statements.
###
